These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10369274)

  • 1. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer.
    Alavi S; Namazie A; Calcaterra TC; Wang MB; Srivatsan ES
    Laryngoscope; 1999 Jun; 109(6):874-9. PubMed ID: 10369274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
    Wang MB; Alavi S; Engstrom M; Lee J; Namazie A; Moatamed F; Srivatsan ES
    Anticancer Res; 1999; 19(2A):925-31. PubMed ID: 10368635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
    Meredith SD; Levine PA; Burns JA; Gaffey MJ; Boyd JC; Weiss LM; Erickson NL; Williams ME
    Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):790-4. PubMed ID: 7598859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
    Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21-q29 in head and neck carcinomas.
    Jin Y; Jin C; Wennerberg J; Höglund M; Mertens F
    Int J Cancer; 2002 Mar; 98(3):475-9. PubMed ID: 11920603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q.
    Jin Y; Höglund M; Jin C; Martins C; Wennerberg J; Akervall J; Mandahl N; Mitelman F; Mertens F
    Genes Chromosomes Cancer; 1998 Aug; 22(4):312-20. PubMed ID: 9669669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
    Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
    Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma.
    Parikh RA; White JS; Huang X; Schoppy DW; Baysal BE; Baskaran R; Bakkenist CJ; Saunders WS; Hsu LC; Romkes M; Gollin SM
    Genes Chromosomes Cancer; 2007 Aug; 46(8):761-75. PubMed ID: 17492757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
    J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
    Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
    Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
    Muller D; Millon R; Velten M; Bronner G; Jung G; Engelmann A; Flesch H; Eber M; Methlin G; Abecassis J
    Eur J Cancer; 1997 Nov; 33(13):2203-10. PubMed ID: 9470807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue.
    Fujii M; Ishiguro R; Yamashita T; Tashiro M
    Cancer Lett; 2001 Oct; 172(2):187-92. PubMed ID: 11566495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas.
    Lese CM; Rossie KM; Appel BN; Reddy JK; Johnson JT; Myers EN; Gollin SM
    Genes Chromosomes Cancer; 1995 Apr; 12(4):288-95. PubMed ID: 7539284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
    Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
    Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.